https://orcid.org/0000-0003-2022-5859
References
- Mak WY, Zhao M, Ng SC, et al. The epidemiology of inflammatory bowel disease: east meets west. J Gastroenterol Hepatol. 2020;35(3):380–389. doi: 10.1111/jgh.14872
- Lee HH, Bae JM, Lee BI, et al. Pregnancy outcomes in women with inflammatory bowel disease: a 10-year nationwide population-based cohort study. Aliment Pharmacol Ther. 2020 May;51(9):861–869. doi: 10.1111/apt.15654
- Baird DD, Narendranathan M, Sandler RS Increased risk of preterm birth for women with inflammatory bowel disease. Gastroenterology. 1990 Oct;99(4):987–94. doi: 10.1016/0016-5085(90)90617-A
- Torres J, Chaparro M, Julsgaard M, et al. European Crohn’s and colitis guidelines on sexuality, fertility, pregnancy, and lactation. J Crohns Colitis. 2022Aug 25;17(1):1–27.
- Pedersen N, Bortoli A, Duricova D, et al. The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom study of 209 pregnant women. Aliment Pharmacol Ther. 2013 Sep;38(5):501–12.
- Selinger C, Carey N, Cassere S, et al. Standards for the provision of antenatal care for patients with inflammatory bowel disease: guidance endorsed by the British society of gastroenterology and the British maternal and fetal medicine society. Frontline Gastroenterol. 2020;12(3):182–187. doi: 10.1136/flgastro-2020-101459
- Laube R, Yau Y, Selinger CP, et al. Knowledge and attitudes towards pregnancy in females with inflammatory bowel disease: an international, multi-centre study. J Crohns Colitis. 2020 Sep 16;14(9):1248–1255. doi: 10.1093/ecco-jcc/jjaa047
- de Lima A, Zelinkova Z, Mulders AG, et al. Preconception care reduces relapse of inflammatory bowel disease during pregnancy. Clin Gastroenterol Hepatol. 2016 Mar 18;14(9):1285–1292.e1. doi: 10.1016/j.cgh.2016.03.018
- Mahadevan U, Long MD, Kane SV, et al. Pregnancy and neonatal outcomes after fetal exposure to biologics and thiopurines among women with inflammatory bowel disease. Gastroenterology. 2021 Mar;160(4):1131–1139. doi: 10.1053/j.gastro.2020.11.038
- Julsgaard M, Wieringa JW, Baunwall SMD, et al. Infant ustekinumab clearance, risk of infection, and development after exposure during pregnancy. Clin Gastroenterol Hepatol. 2024 Jan 24. doi: 10.1016/j.cgh.2024.01.008
- Monfared N, Gold M, Carbery I, et al. Reproductive safety issues of novel small molecules for the treatment of inflammatory bowel disease: a systematic review. J Clin Med. 2024;13(1):34. doi: 10.3390/jcm13010034